Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 33

    Manipal bid to buyout Medanta for Rs 5800 crore: Report

    Manipal bid to buyout Medanta for Rs 5800 crore: Report

    Garima29 April 2019 12:20 PM IST
    MUMBAI: Cardiologist Naresh Trehan owned Medanta buyout is likely to conclude as TPG and Temasek-backed Manipal Hospitals has recently submitted a...
    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Meghna A Singhania28 April 2019 12:04 PM IST
    Vadodara: Stressing on the authenticity of medical treatment provided by a medical practitioner, a consumer court has made an incisive observation and...
    CDSCO to hire 754 Regulatory Officers especially to regulate Medical Devices in country:DTAB

    CDSCO to hire 754 Regulatory Officers especially to regulate Medical Devices in country:DTAB

    Meghna A Singhania27 April 2019 3:00 PM IST
    New Delhi: With the various controversies relating to medical devices taking the limelight, the Government is looking forward to recruiting 754...
    Sun Pharma gets 11 USFDA observations for Dadra plant, BSE asks for response: Report

    Sun Pharma gets 11 USFDA observations for Dadra plant, BSE asks for response: Report

    Farhat Nasim26 April 2019 2:20 PM IST
    New Delhi: Sun Pharmaceutical (Sun Pharma) Industries Ltd's Dadra plant has reportedly received 11 observations, "serious" in nature from the U.S....
    Ban on online sale of medicines: Delhi HC issues notice to Centre, e-pharmacies on contempt plea

    Ban on online sale of medicines: Delhi HC issues notice to Centre, e-pharmacies on contempt plea

    Meghna A Singhania25 April 2019 2:21 PM IST
    The council claimed that the e-pharmacies in willful disobedience of the order passed by the high court are selling medicines online.New Delhi: The...
    Sole Bidder of SevenHills Hospital to restart operations, gets NCLT tribunal nod

    Sole Bidder of SevenHills Hospital to restart operations, gets NCLT tribunal nod

    Farhat Nasim24 April 2019 5:31 PM IST
    Mumbai: The fate of SevenHills Hospital has finally been pronounced as the National Company Law Tribunal (NCLT) has ruled in favour of BR Shetty, the...
    Now State Drug Controllers to have authority to issue STOP SALE order of Medicines: CDSCO to amend to rule

    Now State Drug Controllers to have authority to issue STOP SALE order of Medicines: CDSCO to amend to rule

    Meghna A Singhania23 April 2019 12:20 PM IST
    New Delhi: Empowering State Drug Controllers, the Government will soon amend Rule 66 of Drugs and Cosmetics (D&C) Rules, 1940 thereby granting...
    Patent Infringement: Cadila Healthcare, two others prohibited from launching Linagliptin Metformin Hydrochloride tablets

    Patent Infringement: Cadila Healthcare, two others prohibited from launching Linagliptin Metformin Hydrochloride tablets

    Meghna A Singhania22 April 2019 2:07 PM IST
    AHMEDABAD: In a major setback, three Gujarat based pharmaceutical companies including Cadila Healthcare, West Coast Pharmaceutical Works Ltd and Maan...
    Drugs registered on SUGAM portal to be exempted from obtaining licence for purpose of examination, test, analysis

    Drugs registered on SUGAM portal to be exempted from obtaining licence for purpose of examination, test, analysis

    Meghna A Singhania21 April 2019 2:26 PM IST
    The exemption from obtaining a licence for Form 29 is subject to the condition that the information about the manufacturing of approved drugs for...
    Chemists and Druggists or Pharmacy? DTAB decides on nomenclature

    Chemists and Druggists or Pharmacy? DTAB decides on nomenclature

    Meghna A Singhania20 April 2019 11:44 AM IST
    New Delhi: The highest statutory decision-making body under CDSCO, Drug Technical Advisory Board (DTAB) has given its in principal nod to replace the...
    Mandatory QR coding for APIs soon: DTAB

    Mandatory QR coding for APIs soon: DTAB

    Meghna A Singhania19 April 2019 11:21 AM IST
    New Delhi: Drugs Technical Advisory Board (DTAB), functional under the Central Drugs and Standard (CDSCO) has recommended “making it mandatory to have...
    Government to revise limit of free salicylic acid content in drugs containing ASPIRIN

    Government to revise limit of free salicylic acid content in drugs containing ASPIRIN

    Meghna A Singhania18 April 2019 3:13 PM IST
    New Delhi: Government is soon going to revise the limit of free salicylic acid content in medicines containing Aspirin, as the Drugs and Techincal...
    PrevNext

    Popular Stories

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok